NetworkNewsBreaks

WednesdayMar 30, 2022 2:29 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 24th Patent Sets the Stage for New Market Opportunities in Australia

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, celebrated the receipt of its 24th granted patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” Granted in Australia, this is the first patent awarded from the company’s 8th patent family. “The new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine and other nicotine complexes,” reads a recent article. Prior to the…

Continue Reading

WednesdayMar 30, 2022 1:47 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Releases Spring 2022 Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced its spring 2022 Robot Roadshow schedule. Designed to be an engaging experiential event that allows Knightscope to connect with potential clients and showcase its proprietary crime-fighting robots, the Robot Roadshow will begin on April 12, 2022, and will tour 10 states, including Minnesota, Wisconsin, Illinois, Indiana and Ohio, with 35 scheduled stops. The roadshow will also be in Washington, D.C. during National Police Week. Creative marketing events such as the Robot Roadshow allow KSCP, a public safety innovator, to educate existing and…

Continue Reading

WednesdayMar 30, 2022 1:35 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host LD Micro Invitational at Four Seasons Westlake Village

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will host the 2022 LD Micro Invitational. The prominent three-day investor conference is slated to take place on June 7-9, 2022, at the Four Seasons Hotel Westlake Village, California. Approximately 200 companies from all over the world will showcase what makes them truly special at the event, each presenting for 25 minutes and finalizing their exhibition with private meetings. SRAX will soon release the link to register for virtual and physical components of the…

Continue Reading

WednesdayMar 30, 2022 1:26 pm

NetworkNewsBreaks – Advisors Mortgage Group LLC’s President Named Among 2022 NJBIZ Leaders in Finance

Advisors Mortgage Group, based in Ocean Township, New Jersey, today announced that the company’s President Steven Meyer was named one of the honorees of the 2022 NJBIZ Leaders in Finance awards. The awards celebrate New Jersey’s financial executives at all levels who contribute to the success of their companies and communities. According to information from NJBIZ, honorees were chosen by a panel of independent judges with experience in the financial field following an open nomination period. The selections were based on the nominees’ involvement in their industries and communities, as well as their achievements, energy and innovative ideas. “I am…

Continue Reading

WednesdayMar 30, 2022 1:04 pm

NetworkNewsBreaks – Feed Every Gorilla Eyes the Coming Year as ‘One for the History Books’

Since its launch in early 2021, the Feed Every Gorilla (“FEG”) Token project has repeatedly exceeded expectations, rapidly pushing out next-gen tech. Some of the revolutionary technologies laying the foundation for the next phase of growth and expansion include the decentralized and community-owned FEG Exchange (“FEGex”), the honey pot-proof SmartSwap system, the second-to-none fWrapping system and the groundbreaking SmartDeFi cryptocurrency launchpad. After closing out its first hugely successful year, the FEG project will turn heads and change crypto forever with its roadmap expansion. The recent announcement of upcoming technology releases will undoubtedly catapult FEG into the forefront, further demonstrating the…

Continue Reading

WednesdayMar 30, 2022 1:00 pm

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Subsidiary Expands Treatment Options to Add FDA-Approved Esketamine Nasal Spray

Delic Holdings’ (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) subsidiary, Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S., has expanded its treatment options to include SPRAVATO(R) nasal spray. KWC clinics located in Houston, Las Vegas and Seattle will begin offering this treatment option on April 1. According to the announcement, SPRAVATO is taken with an oral antidepressant and is the first FDA-approved esketamine nasal spray for adults with treatment-resistant depression (“TRD”) or to treat depressive symptoms in adults with major depressive disorder (“MDD”) with suicidal thoughts or actions. Patients interested in the treatment option will first undergo…

Continue Reading

WednesdayMar 30, 2022 12:34 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Announces Expansion of Cannabis Delivery Business, New Distribution Model with Dining Partnership

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, has signed two definitive agreements designed to expand the company’s footprint. One of the agreements establishes SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub on Strip as well as a minority stake in an expanding reservation-only restaurant brand that offers a private event space that allows cannabis consumption. The announcement also noted that SGMD will have majority ownership in a brand-new cannabis retail distribution hub offering delivery in the affluent neighborhoods of the West Hollywood Hills. Sugarmade also inked a deal…

Continue Reading

WednesdayMar 30, 2022 12:03 pm

NetworkNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) CEO Slated to Present Keynote at Upcoming Plant Medicine Week Conference

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will be participating in the Plant Medicine Week conference, which is scheduled to be held April 5–8, 2022, in Malta. Flora Growth chair and CEO Luis Merchan is the keynote speaker at the four-day event. Merchan’s presentation, titled “Malta — The Gateway to South American and European Cannabis Relations,'' is slated to start at 2:30 CET and will focus on the opportunity presented by Malta’s standpoint on cannabis as well as the cost advantages of South American cultivation and the broader European opportunity. The…

Continue Reading

WednesdayMar 30, 2022 11:53 am

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has partnered with InvestorBrandNetwork (“IBN”) for its corporate communications. IBN is a multifaceted financial news and publishing company focused on private and public entities. Silo works to develop innovative solutions that address serious conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease and other rare neurological disorders. The company is committed to identifying and partnering with leading medical universities; SILO provides invaluable financial resources to develop safe therapeutic treatments while advancing research through clinical stage studies and trials and into…

Continue Reading

TuesdayMar 29, 2022 2:31 pm

NetworkNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Moving to Become Trusted Source of Effective Medication-Based Treatments

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has continually taken steps toward fulfilling its mission to become a trusted source of safe and effective medication-based treatments for mental health and addiction disorders. These strategic moves include developing drug candidates, partnering to advance research and more. The company has partnered with Dr. Matthew W. Johnson, Ph.D., a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University (“JHU”), to lead its planned placebo-controlled study evaluating the science and efficacy of MYCO-001, its lead psilocybin-based drug…

Continue Reading